On November 22, 2021 Notable Labs, Inc. (Notable), a clinical-stage platform therapeutics company, reported two abstracts have been accepted for poster presentation at the 63rd American Society of Hematology (ASH) (Free ASH Whitepaper) Annual Meeting and Exposition (Press release, Notable Labs, NOV 22, 2021, View Source [SID1234595875]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"These two clinical projects provide further validation of the Notable predictive precision medicine platform. The exciting data advance our mission to design and deliver predictive precision medicines by matching treatments with precisely the patients who clinically respond to them," says Joe Wagner, PhD, Chief Scientific Officer of Notable.

The meeting will be held virtually and in person in Atlanta, GA, from December 11-14, 2021.

Abstract details:
Title: Ex Vivo Drug Sensitivity Assay Correlates with Clinical Response and Identifies Panobinostat and Bortezomib As a Potential Novel Drug Combination for Pediatric AML
Publication Number: 2361
Submission ID: 145275
Authors: Debbie Strachan, Ph.D. et al.
Session Name: 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster II
Poster Presentation Date and Time: Sunday, December 12, 2021, 6:00 PM-8:00 PM
Location: Georgia World Congress Center, Hall B5
Title: Prediction of Clinical Response to Venetoclax Plus Decitabine in AML Using a 7-Day Ex Vivo Assay
Publication Number: 3464
Submission ID: 148891
Authors: Markus Lacher, Ph.D. et al.
Session Name: 617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis: Poster III
Poster Presentation Date and Time: Monday, December 13, 2021, 6:00 PM-8:00 PM
Location: Georgia World Congress Center, Hall B5
The posters will be available for viewing on December 11, 2021 at 9 a.m. ET and will be available on Notable’s website following their presentations.

For more details about the ASH (Free ASH Whitepaper) Annual Meeting please visit: View Source